SLC22A18 Antibody
-
中文名稱：SLC22A18兔多克隆抗體
-
貨號：CSB-PA011444
-
規(guī)格：￥2024
-
圖片：
-
Western blot analysis of extracts from COLO205 cells, using ORCTL-2 antibody.
-
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱：Rabbit anti-Homo sapiens (Human) SLC22A18 Polyclonal antibody
-
Uniprot No.：
-
基因名：SLC22A18
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Synthesized peptide derived from C-terminal of Human ORCTL-2.
-
免疫原種屬：Homo sapiens (Human)
-
克隆類型：Polyclonal
-
純化方式：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
濃度：It differs from different batches. Please contact us to confirm it.
-
產(chǎn)品提供形式：Liquid
-
應(yīng)用范圍：ELISA,WB
-
推薦稀釋比：
Application Recommended Dilution WB 1:500-1:3000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情
-
功能：May act as a transporter of organic cations based on a proton efflux antiport mechanism. May play a role in the transport of chloroquine and quinidine-related compounds in kidney.
-
基因功能參考文獻：
- Data provide evidence that SLC22A18 and/or CDKN1C are tumor modifier genes involved in the tumorigenesis of SDHD-mutated paraganglioma. PMID: 27402879
- Establish SLC22A18 as a tumor suppressor in colon epithelial cells and propose that SLC22A18 is potentially a marker of diagnostic and prognostic values. PMID: 26196590
- microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18 PMID: 25498886
- Upregulated expression of SLC22A18 enhanced the radiosensitivity of glioma U251 cells. PMID: 24481489
- SLC22A18 protein expression predicted a significantly shorter overall survival in 51 patients receiving TMZ therapy, whereas no differences in overall survival were observed in 35 patients without TMZ therapy PMID: 23514245
- SLC22A18 functions as a tumor suppressor in glioma and represents a candidate biomarker for long-term survival in this disease. PMID: 22153794
- The expression level of SLC22A18 in non-small cell lung cancer was significantly higher than that in normal tissue. PMID: 22237119
- SLC22A18 downregulation via promoter methylation is associated with the development and progression of glioma. PMID: 21936894
- Low expression of SLC22A18 was associated with tumor progression, recurrence and poor survival after breast surgery PMID: 21144813
- SLC22A18 gene is imprinted, with preferential expression from the maternal allele. PMID: 9751628
- involved in the drug resistance mechanism of tumors PMID: 11925925
- UbcH6-RING105 may define a novel ubiquitin-proteasome pathway that targets TSSC5 in mammalian cells PMID: 16314844
- study reports the imprinting status of SLC22A18AS in breast tissue and breast cancer, and shows that gain of imprinting affects both the sense, and antisense transcripts at this locus PMID: 16624517
- Mutational analysis of the two Sp1 sites suggested their requirement for the promoter activityof SLC22A18. PMID: 18996451
- recent demonstration that the promoter of this gene is positively regulated by Sp1 PMID: 18996451
顯示更多
收起更多
-
相關(guān)疾病：Lung cancer (LNCR); Rhabdomyosarcoma, embryonal, 1 (RMSE1)
-
亞細(xì)胞定位：Apical cell membrane; Multi-pass membrane protein.
-
蛋白家族：Major facilitator (TC 2.A.1) superfamily, Organic cation transporter (TC 2.A.1.19) family
-
組織特異性：Expressed at high levels in adult and fetal kidney and liver, and adult colon. Expressed in fetal renal proximal tubules (at protein level). Expressed at lower levels in heart, brain and lung.
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
